CN104771627A - Traditional Chinese medicine composition for treating uterine prolapse - Google Patents
Traditional Chinese medicine composition for treating uterine prolapse Download PDFInfo
- Publication number
- CN104771627A CN104771627A CN201510160006.XA CN201510160006A CN104771627A CN 104771627 A CN104771627 A CN 104771627A CN 201510160006 A CN201510160006 A CN 201510160006A CN 104771627 A CN104771627 A CN 104771627A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- uterine prolapse
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating uterine prolapse, which can conduce to effectively solving the problem of medication of uterine prolapse. The traditional Chinese medicine composition is prepared from the following raw medicines in parts by weight: 10-40 parts of herb of palmgrass, 10-30 parts of radix astragali, 5-15 parts of largetrifoliolious bugbane rhizome, 5-15 parts of bitter orange, 10-20 parts of cherokee rose fruit, 5-15 parts of cuttlebone, 10-20 parts of limonite, 5-15 parts of dried human placenta and 5-20 parts of deerhorn glue. The traditional Chinese medicine composition has the beneficial effects that the traditional Chinese medicine composition is rich in raw materials and is low in price; the components are scientific, are reasonable in compatibility and support each other; the medicines jointly have the functions of invigorating the spleen-stomach, replenishing qi and ascending qi and reinforcing the vital essence and inducing astringency; the traditional Chinese medicine composition is used for effectively treating uterine prolapse, has good curative effects, is safe in medication and is a great innovation of medicines for treating uterine prolapse.
Description
Technical field
The present invention relates to field of medicaments, particularly a kind of Chinese medicine composition for the treatment of uterine prolapse.
Background technology
Uterine prolapse, motherland's medical science is referred to as the prolapse of the uterus, prolapse of the uterus etc.The cause of disease mostly is that delivery and feed infant is too much, and during childbirth, stages of labor is long, overexertion or deal with improperly, damages collaterals of the uterus; Or puerperal participate in heavy physical labour too early, after standing and position of squatting for a long time; Or have a delicate constitution, chronic cough, constipation, diarrhoea etc. cause abdominal pressure to increase, and make pelvic diaphragm muscle and fascia overextension or damage.Patient is because of overstrain, fecund, and damage spleen kidney, deficiency of spleen-QI is sinking of QI of middle-JIAO then, and kidney qi loss causes dai channel and fails to keep an appointment, the debility of CHONG and REN meridians, unablely maintains uterus, and uterine ligaments relaxes, and uterus loses suspention and sends out primary disease.Western medical treatment is based on supporting treatment, pessulum or operative treatment, and clinical efficacy is not obvious.Therefore, the improvement and bring new ideas for the treatment of on uterine prolapse medicine is the problem needing solution at present badly.
Summary of the invention
For above-mentioned situation, for solving the defect of prior art, the object of the present invention is just to provide a kind of Chinese medicine composition for the treatment of uterine prolapse, effectively can solve the medication problem of uterine prolapse.
The technical scheme that the present invention solves is made up of the material medicine of following weight parts: Herba Setariae palmifoliae 10-40 part, Radix Astragali 10-30 part, Rhizoma Cimicifugae 5-15 part, Fructus Aurantii 5-15 part, Fructus Rosae Laevigatae 10-20 part, Endoconcha Sepiae 5-15 part, Limonitum 10-20 part, Placenta Hominis 5-15 part and Colla cornus cervi 5-20 part.
Abundant raw material of the present invention, cheap, component science, reasonable compatibility, supports mutually, and all medicines play invigorating the spleen and replenishing QI ascending, the first astringent or styptic treatment for spontaneous sweating effect of training altogether, are effective to treat uterine prolapse, good effect, drug safety, is that on treatment uterine prolapse medicine innovates greatly.
Detailed description of the invention
Below in conjunction with embodiment, the specific embodiment of the present invention is described in further detail.
Embodiment 1
The present invention in the specific implementation, can be made up of the material medicine of following weight parts: Herba Setariae palmifoliae 10 parts, the Radix Astragali 30 parts, Rhizoma Cimicifugae 5 parts, Fructus Aurantii 15 parts, Fructus Rosae Laevigatae 10 parts, Endoconcha Sepiae 15 parts, Limonitum 10 parts, Placenta Hominis 15 parts and Colla cornus cervi 5 parts.
Embodiment 2
The present invention in the specific implementation, also can be made up of the material medicine of following weight parts: Herba Setariae palmifoliae 25 parts, the Radix Astragali 20 parts, Rhizoma Cimicifugae 10 parts, Fructus Aurantii 10 parts, Fructus Rosae Laevigatae 15 parts, Endoconcha Sepiae 10 parts, Limonitum 15 parts, Placenta Hominis 10 parts and Colla cornus cervi 12 parts.
Embodiment 3
The present invention in the specific implementation, also can be made up of the material medicine of following weight parts: Herba Setariae palmifoliae 40 parts, the Radix Astragali 10 parts, Rhizoma Cimicifugae 15 parts, Fructus Aurantii 5 parts, Fructus Rosae Laevigatae 20 parts, Endoconcha Sepiae 5 parts, Limonitum 20 parts, Placenta Hominis 5 parts and Colla cornus cervi 20 parts.
Embodiment 4
The present invention in the specific implementation, also can be made up of the material medicine of following weight parts: Herba Setariae palmifoliae 10-25 part, Radix Astragali 10-25 part, Rhizoma Cimicifugae 5-10 part, Fructus Aurantii 5-10 part, Fructus Rosae Laevigatae 10-15 part, Endoconcha Sepiae 5-10 part, Limonitum 10-15 part, Placenta Hominis 5-10 part and Colla cornus cervi 5-12 part.
Embodiment 5
The present invention in the specific implementation, also can be made up of the material medicine of following weight parts: Herba Setariae palmifoliae 26-40 part, Radix Astragali 26-30 part, Rhizoma Cimicifugae 11-15 part, Fructus Aurantii 11-15 part, Fructus Rosae Laevigatae 16-20 part, Endoconcha Sepiae 11-15 part, Limonitum 11-20 part, Placenta Hominis 11-15 part and Colla cornus cervi 13-20 part.
Chinese medicine composition of the present invention can according to the needs of clinical practice, preparation method makes decoction routinely, powder (powder), tablet, granule, pill, capsules etc. are suitable for the various dosage forms applied, provide the decoction that conventional method is made below, specifically: first by Herba Setariae palmifoliae, the Radix Astragali, Rhizoma Cimicifugae, Fructus Aurantii, Fructus Rosae Laevigatae, Endoconcha Sepiae, Limonitum, Placenta Hominis and Colla cornus cervi mix, put into medicinal cupping, add water to submerge, soak 30-60min, intense fire decocts to boiling, use slow fire boiling 20-30min instead, filter, obtain filtrate, filtering residue adds water to submerge again, intense fire decocts to boiling, use slow fire boiling 20-30min instead, filter, obtain filtrate, merge twice filtrate, mixing.
In instant component:
Herba Setariae palmifoliae: sweet, warm.Return spleen channel.Supplementing QI to prevent collapse.Clinical in proctoptosis, the diseases such as uterine prolapse.
The Radix Astragali: sweet, temperature.Return lung, spleen channel.Invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, expelling pus and promoting granulation.Weak for the deficiency of vital energy, anorexia and loose stool, sinking of QI of middle-JIAO, chronic diarrhea proctoptosis, metrorrhagia of having blood in stool, exterior deficiency spontaneous perspiration, deficiency of vital energy edema, carbuncle difficulty is burst, and burst for a long time and do not hold back, blood deficiency dull yellowish colored skin, interior-heat is quenched one's thirst; Chronic nephritis proteinuria, diabetes.
Rhizoma Cimicifugae: pungent, micro-sweet, is slightly cold.Return lung, spleen, stomach, large intestine channel.Deliver rash, heat-clearing and toxic substances removing, elevate a turnable ladder yang-energy.For headache due to pathogenic wind-heat, toothache, aphtha, laryngopharynx swelling and pain, measles without adequate eruption, YANG toxin syndrome sends out speckle; Proctoptosis, uterine prolapse.
Fructus Aurantii: bitter, pungent, sour, temperature.Return spleen, stomach warp.Regulating the flow of QI to ease the stomach, the stagnant relieving distension of row.For the breast side of body stagnation of QI, distension pain, accumulation of food in the stomach and intes tine due to indigestion, stops in phlegm retention; Gastroptosis, proctoptosis, sub-official's prolapsus.
Fructus Rosae Laevigatae: sour, sweet, puckery, flat.Return kidney, bladder, large intestine channel.Controlling nocturnal emission with astringent drugs reducing urination, relieving diarrhea with astringents.For emission and spermatorrhea, enuresis frequent micturition, bleeding not during menses, chronic diarrhea chronic dysentery.
Endoconcha Sepiae: salty, puckery, temperature.Return spleen, kidney channel.Astringing to arrest bleeding, relieving leukorrhea by astringents, antacid, sore.For acid regurgitation of having a stomachache, hematemesis and epistaxis, metrorrhagia is had blood in stool, emission and spermatorrhea, leucorrhea with red and white discharge; Peptic Ulcers.External treatment bleeding due to trauma, the many pus of skin ulcer.
Limonitum: sweet, puckery, is slightly cold.Return stomach, large intestine channel.Relieving diarrhea with astringents, astringing to arrest bleeding.For chronic diarrhea, chronic dysentery, metrorrhagia, leucorrhea.
Placenta Hominis: sweet, salty, temperature.GUIXIN, lung, kidney channel.The kidney warming mends essence, benefiting QI and nourishing blood.For asthenia weakness and emaciation, hectic fever due to YIN-deficiency night sweat, cough and asthma, lack of appetite is breathed hard, impotence and seminal emission, infertile hypogalactia.
Colla cornus cervi: sweet, salty, temperature.Return kidney, Liver Channel.Temperature compensation Liver and kidney, beneficial intensive culture blood.For sexual impotence spermatorrhea, the acid of waist knee joint is cold, asthenia weakness and emaciation, metrostaxis, and hematuria of having blood in stool, carbuncle of yin nature swells and ache.
The Chinese medicine composition that the present invention treats uterine prolapse is based on fundamental Chinese medicine theory, develops and has invigorating the spleen and replenishing QI ascending, the Chinese medicine composition of effect that training unit is astringent or styptic treatment for spontaneous sweating.The Radix Astragali, Herba Setariae palmifoliae tonifying and lifting QI in prescription; Rhizoma Cimicifugae yang invigorating; Fructus Aurantii regulating the flow of QI to ease the stomach, the stagnant relieving distension of row; Fructus Rosae Laevigatae, Endoconcha Sepiae, Limonitum convergence is solid de-; Placenta Hominis, Colla cornus cervi kidney tonifying, essence replenishing.Full side's the kidney invigorating is admittedly de-, tonifying and lifting QI, utilizes the comprehensive function treatment uterine prolapse of every Chinese medicine, harmless to human non-toxic, good effect, drug safety, and obtains sufficient proof through clinical experiment, and pertinent clinical experimental data is as follows:
Chinese medicine composition of the present invention for decoction,
1, physical data
In 120 routine patients, be divided into treatment group and matched group at random.Treatment group 60 example, 35 ~ 65 years old age, average (48.38 ± 12.71) year; Pregnant time 1 ~ 4 time, average (1.67 ± 0.42) are secondary; The course of disease 2 ~ 14 years, average (7.5 ± 2.16) year; Uterine prolapse I degree of 18 example, II degree of 12 example.Matched group 60 example, 32 ~ 67 years old age, average (46.12 ± 10.89) year; Pregnant time 1 ~ 3 time, average (1.75 ± 0.52) are secondary; The course of disease 2 ~ 15 years, average (8.2 ± 2.73) year; Uterine prolapse I degree of 17 example, II degree of 13 example.2 groups of data are through statistical procedures, and in age, the state of an illness, difference there are no significant meaning (P>0.05), has comparability.
2, case inclusive criteria
Selected patient is First episode, and without regular treatment; With anterior vaginal wall or descent vaginae posterior; Get rid of uterine prolapse with severe complication persons such as the serious heart, brain, kidneys; Uterine prolapse is with Pelvic floor atrophy person; Uterine prolapse companion severe cervical canker sore, infection suppurates and congenital cervix uteri prolong elder.
3, therapeutic scheme
Treatment group: use Chinese medicine composition of the present invention to make decoction, sooner or later respectively once, decoction being taken warmly, each 200-300ml.
Matched group: adopt supporting treatment, comprise reinforcement nutrition, reasonable arrangement is had a rest and work, avoid heavy physical labour, avoid the action of increase abdominal pressures such as standing for a long time or squat down, hold one's breath, keep free movement of the bowels, keep perineal position to clean, actively carry out gymnastic to temper pelvic floor muscles and abdominal wall muscle.As enjoin patient's row shrink anus motion, namely anus one contract one loosen do, every day 2 times, each 10 minutes; Row knee chest position is practised: emptying urine, loosens one's waistband, and whole body loosens, and kneel on hardboard bed, head is put in bed, and face turns to side, and the micro-Qu Qianshen of two-arm, buttocks is raised with thigh rectangular.Sooner or later each 1 time, each 10 minutes.
Treatment group and matched group are 30 days the course for the treatment of, add up curative effect after the course for the treatment of.
4, efficacy assessment standard
Cure: transference cure, more than cervix uteri mouth location restore ischial spine level;
Effective: transference cure, uterus is returned and is contained in intravaginal, and cervical orifice is close to ischial spine level;
Effective: symptom comparatively before take a turn for the better, uterus is returned and is received vagina situation and slightly improve;
Invalid: symptom without improvement, uterus return receive vagina situation comparatively treat before without improve.
5, statistical procedures
Adopt SPSS13.0 statistical software, enumeration data adopts x2 inspection, and ranked data adopt Ridit inspection.
By above-mentioned therapeutic scheme, the Chinese medicine composition decoction that oral the present invention provides, as can be seen from Table 1, and treatment group recovery from illness 26 example, effective 18 examples, effective 14 examples, invalid 2 examples, total effective rate is 96.66%; Matched group recovery from illness 10 example, effective 12 examples, effective 20 examples, invalid 18 examples, total effective rate is 70%.Treatment group compares with matched group, and recovery from illness, invalid and total effective rate have remarkable significant difference.
table 1 liang group Clinical efficacy comparison
Compare with matched group, * P < 0.05, * * P < 0.01
Chinese medicine composition of the present invention is through making other dosage forms; all achieve identical or close result in an experiment; will not enumerate, prevent tired stating, and; what the application's request was protected is Chinese medicine composition (component invention); and do not lie in dosage form or preparation method, and therefore, arbitrary dosage form that all employing the application Chinese medicine compositions are made; and be used for the treatment of the medicine of uterine prolapse, all belong to the scope of the application's protection.
6, conclusion
Component science of the present invention, abundant raw material, cheap, reasonable compatibility, mutual support, all medicines play invigorating the spleen and replenishing QI ascending, the first astringent or styptic treatment for spontaneous sweating effect of training altogether, are effective to treat uterine prolapse, good effect, drug safety, effective percentage, up to more than 96%, is that on treatment uterine prolapse medicine innovates greatly, has actual clinical meaning.
Claims (7)
1. treat the Chinese medicine composition of uterine prolapse for one kind, it is characterized in that, be made up of the material medicine of following weight parts: Herba Setariae palmifoliae 10-40 part, Radix Astragali 10-30 part, Rhizoma Cimicifugae 5-15 part, Fructus Aurantii 5-15 part, Fructus Rosae Laevigatae 10-20 part, Endoconcha Sepiae 5-15 part, Limonitum 10-20 part, Placenta Hominis 5-15 part and Colla cornus cervi 5-20 part.
2. the Chinese medicine composition for the treatment of uterine prolapse according to claim 1, it is characterized in that, be made up of the material medicine of following weight parts: Herba Setariae palmifoliae 10 parts, the Radix Astragali 30 parts, Rhizoma Cimicifugae 5 parts, Fructus Aurantii 15 parts, Fructus Rosae Laevigatae 10 parts, Endoconcha Sepiae 15 parts, Limonitum 10 parts, Placenta Hominis 15 parts and Colla cornus cervi 5 parts.
3. the Chinese medicine composition for the treatment of uterine prolapse according to claim 1, it is characterized in that, be made up of the material medicine of following weight parts: Herba Setariae palmifoliae 25 parts, the Radix Astragali 20 parts, Rhizoma Cimicifugae 10 parts, Fructus Aurantii 10 parts, Fructus Rosae Laevigatae 15 parts, Endoconcha Sepiae 10 parts, Limonitum 15 parts, Placenta Hominis 10 parts and Colla cornus cervi 12 parts.
4. the Chinese medicine composition for the treatment of uterine prolapse according to claim 1, it is characterized in that, be made up of the material medicine of following weight parts: Herba Setariae palmifoliae 40 parts, the Radix Astragali 10 parts, Rhizoma Cimicifugae 15 parts, Fructus Aurantii 5 parts, Fructus Rosae Laevigatae 20 parts, Endoconcha Sepiae 5 parts, Limonitum 20 parts, Placenta Hominis 5 parts and Colla cornus cervi 20 parts.
5. the Chinese medicine composition for the treatment of uterine prolapse according to claim 1, it is characterized in that, be made up of the material medicine of following weight parts: Herba Setariae palmifoliae 10-25 part, Radix Astragali 10-25 part, Rhizoma Cimicifugae 5-10 part, Fructus Aurantii 5-10 part, Fructus Rosae Laevigatae 10-15 part, Endoconcha Sepiae 5-10 part, Limonitum 10-15 part, Placenta Hominis 5-10 part and Colla cornus cervi 5-12 part.
6. the Chinese medicine composition for the treatment of uterine prolapse according to claim 1, it is characterized in that, be made up of the material medicine of following weight parts: Herba Setariae palmifoliae 26-40 part, Radix Astragali 26-30 part, Rhizoma Cimicifugae 11-15 part, Fructus Aurantii 11-15 part, Fructus Rosae Laevigatae 16-20 part, Endoconcha Sepiae 11-15 part, Limonitum 11-20 part, Placenta Hominis 11-15 part and Colla cornus cervi 13-20 part.
7. the Chinese medicine composition of claim 1 or the treatment uterine prolapse described in any one of 2-6, preparation method makes the one of decoction, powder, tablet, granule, pill, capsule routinely.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510160006.XA CN104771627B (en) | 2015-04-07 | 2015-04-07 | A kind of Chinese medicine composition for treating the prolapse of uterus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510160006.XA CN104771627B (en) | 2015-04-07 | 2015-04-07 | A kind of Chinese medicine composition for treating the prolapse of uterus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104771627A true CN104771627A (en) | 2015-07-15 |
| CN104771627B CN104771627B (en) | 2018-02-13 |
Family
ID=53613609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510160006.XA Expired - Fee Related CN104771627B (en) | 2015-04-07 | 2015-04-07 | A kind of Chinese medicine composition for treating the prolapse of uterus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104771627B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105853782A (en) * | 2016-04-12 | 2016-08-17 | 汤华淑 | Traditional Chinese medicinal composition for treating uterine prolapsed |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552531A (en) * | 2012-03-10 | 2012-07-11 | 李承平 | Medicinal composition for tonifying qi and ascending descending qi |
| CN102940716A (en) * | 2012-11-05 | 2013-02-27 | 杜秀兰 | Traditional Chinese medicine for treatment of uterine prolapse |
| CN102961554A (en) * | 2012-11-14 | 2013-03-13 | 凤台县中医院 | Traditional Chinese medicine composition for treating uterine prolapse |
| CN103099993A (en) * | 2013-01-22 | 2013-05-15 | 夏景香 | Traditional Chinese medicine combination for treating uterine prolapse |
-
2015
- 2015-04-07 CN CN201510160006.XA patent/CN104771627B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552531A (en) * | 2012-03-10 | 2012-07-11 | 李承平 | Medicinal composition for tonifying qi and ascending descending qi |
| CN102940716A (en) * | 2012-11-05 | 2013-02-27 | 杜秀兰 | Traditional Chinese medicine for treatment of uterine prolapse |
| CN102961554A (en) * | 2012-11-14 | 2013-03-13 | 凤台县中医院 | Traditional Chinese medicine composition for treating uterine prolapse |
| CN103099993A (en) * | 2013-01-22 | 2013-05-15 | 夏景香 | Traditional Chinese medicine combination for treating uterine prolapse |
Non-Patent Citations (3)
| Title |
|---|
| 夏桂成: "《夏桂成实用中医妇科学》", 31 October 2009 * |
| 旷惠桃 等: "《中医本草疗法（珍藏本）超值版》", 31 August 2012 * |
| 胡献国 等: "《中国膏药配方配制全书》", 30 April 2014 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105853782A (en) * | 2016-04-12 | 2016-08-17 | 汤华淑 | Traditional Chinese medicinal composition for treating uterine prolapsed |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104771627B (en) | 2018-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102552637A (en) | Chinese medicinal composition for treating scapulohumeral periarthritis and preparation method thereof | |
| CN102258658A (en) | Plaster for invigorating blood circulation and relieving pain | |
| CN103285200A (en) | Traditional Chinese medicine for treating multiple osteopathies | |
| CN103041033A (en) | Traditional Chinese medicine composition for treating renal calculus | |
| CN101590185B (en) | Special Chinese medicinal composition for treating femoral head necrosis, and preparation method thereof | |
| CN103908511B (en) | One treats chondromatous Chinese medicinal pill and preparation method | |
| CN105030956A (en) | Nursing traditional Chinese medicine combination used for post-natal rehabilitation | |
| CN103341118A (en) | Medicament for treating threatened abortion and preparation method thereof | |
| CN102949698A (en) | Medicine for treating uterine myoma and preparation method thereof | |
| CN103585596B (en) | Traditional Chinese medicine composition for treating migraine | |
| CN104771627A (en) | Traditional Chinese medicine composition for treating uterine prolapse | |
| CN102988858A (en) | Traditional Chinese medicine composition for treating lumbus and leg pain and ischialgia | |
| CN102058723A (en) | Traditional Chinese medicine for treating impotence, premature ejaculation and sexual dysfunction and preparation method thereof | |
| CN105435195A (en) | Orally-taken medicine for treating prolonged lochia and lesser abdominal pain as well as preparation method of orally-taken medicine | |
| CN104398822A (en) | Traditional Chinese medicine for treating kidney-deficiency uterine prolapse and a preparation method | |
| CN104056173A (en) | Traditional Chinese medicine composition for treating qi and blood deficiency of pregnant women in gestation period | |
| CN104547733A (en) | Traditional Chinese medicine for reducing leucorrhea | |
| CN103356797A (en) | Chinese medicine composition for treating kidney stone | |
| CN103239556A (en) | Traditional Chinese medicine for treating cervical spondylosis caused by wind-cold-dampness arthralgia | |
| CN107334941A (en) | A kind of Chinese medicine for treating chronic pelvic inflammatory disease and preparation method thereof | |
| CN103212010A (en) | Traditional Chinese medicine composition for treating impotence and preparation method thereof | |
| CN102058681A (en) | Traditional Chinese medicine for treating protrusion of lumbar vertebral disc and waist and leg pain and preparation method thereof | |
| CN104771679A (en) | Traditional Chinese medicine for treating uterine prolapse | |
| CN105596886A (en) | Traditional Chinese medicine for preventing recurrence in remission stage of multiple sclerosis | |
| CN105031503A (en) | Traditional Chinese medicine preparation for treating hypertension |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180213 Termination date: 20190407 |